App-Quantinova.ai

EFFICACY OF HYDROXYCHLOROQUINE IN THE TREATMENT OF SYMPTOMATIC KNEE OSTEOARTHRITIS IN OLDER ADULTS: A RANDOMIZED PLACEBO-CONTROLLED TRIAL

S. Abou-Raya - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

Hydroxychloroquine

THE MEDICAL BURDEN OF RARE AUTOINFLAMMATORY DISEASES: EXEMPLE OF MEVALONATE KINASE DEFICIENCY IN FRANCE

C. Galeotti - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Mevalonate kinase deficiency

Hydroxychloroquine

REFRACTORY SARCOID ARTHRITIS IN WORLD TRADE CENTER- EXPOSED NEW YORK CITY FIREFIGHTERS NECESSITATING ANTI-TNF ALPHA THERAPY

K. Loupasakis - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Rheumatoid arthritis

Hydroxychloroquine

CLINICOPATHOLOGICAL ANALYSIS OF 18 CASES OF SPECIFIC SUBCUTANEOUS SARCOIDOSIS IN SOUTH KOREA

S. Moon - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Sarcoidosis

Hydroxychloroquine

LIVER INVOLVEMENT IN ADULT ONSET STIL-S DISEASE: RETROSPECTIVE ANALYSIS OF 18 CASES

F. Ferro - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Pericarditis

Hydroxychloroquine

LONG-TERM TNF? ANTAGONISTS TREATMENT EFFICACY IN AUTOIMMUNE UVEITIS

J. De La Iglesia Salgado - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Rheumatoid arthritis

Hydroxychloroquine

PREDICTIVE VALUE OF PRETREATMENT RESISTIN LEVELS FOR EROSIVE DISEASE IN EARLY RA TREATED WITH DMARDS AND INFLIXIMAB

K. Vuolteenaho - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

A SYSTEMATIC ANALYSIS OF THE SAFETY OF PRESCRIBING OF ANTI-RHEUMATIC, IMMUNOSUPPRESSIVE AND BIOLOGIC DRUGS IN MEN TRYING TO CONCEIVE

S. Panchal - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory bowel disease

Hydroxychloroquine

RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE IS THERE AN ASSOCIATION BETWEEN DISEASE MODIFYING ANTI RHEUMATIC DRUGS AND SURVIVAL?

M. Brown - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Interstitial lung disease

Hydroxychloroquine

HOW MANY PATIENTS FOLLOWED UP WITH RHEUMATOID ARTHRITIS (RA) DIAGNOSIS IS REALLY RA? 1987 ACR CLASSIFICATION CRITERIA COMPARED WITH 2010 ACR/EULAR CRITERIA FOR REAL RA PATIENTS IN TURKEY

Y. Karaaslan - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Giant cell arteritis

Hydroxychloroquine

CHARACTERIZING SERONEGATIVE RHEUMATOID ARTHRITIS

I. Cobb - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Rheumatoid arthritis

Hydroxychloroquine

B-CELL ACTIVATING FACTOR OF THE TUMOR NECROSIS FACTOR FAMILY (BAFF) IN POSTMENOPAUSAL RHEUMATOID ARTHRITIS PATIENTS WITH LOW BONE MASS: A POSSIBLE PROTECTIVE ROLE OF HYDROXYCHLOROQUINE

T. A. Gheita - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

OCULAR TOXICITY INDUCED BY ANTIMALARIAL MEDICATIONS; NECESSITY FOR REGULAR SCREENING

M. Soroush - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

EFFICACY AND TOLERABILITY OF A HOMEOPATHIC MEDICATION INCENA IN PATIENTS WITH RHEUMATOID ARTHRITIS (RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY)

O. Iaremenko - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

OCULAR TOXICITY OF HYDROXYCHLOROQUINE IS MORE FREQUENT IN MALE PATIENTS

O. Helvaci - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

ANALYSIS OF THE LONG-TERM SAFETY OF RITUXIMAB IN PATIENTS WITH CHRONIC INFLAMMATORY ARTHRITIS. OBSERVATIONAL STUDY WITH 7 YEARS FOLLOW-UP

A. Cuervo - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

EFFICACY OF BIOLOGIC TREATMENTS IN EARLY ACTIVE RHEUMATOID ARTHRITIS: AN INDIRECT COMPARISON

L. Sawyer - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

SERUM SURVIVIN IN EARLY RHEUMATOID ARTHRITIS RESULTS FROM THE SWEFOT TRIAL

A. Levitsky - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

IN EARLY UNDIFFERENTIATED ARTHRITIS AUTOANTIBODIES AND POWER DOPPLER IDENTIFY PATIENTS ACHIEVING REMISSION AFTER 12 MONTHS OF TREATMENT

G. Sakellariou - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

USEFULNESS OF THE CLASSIFICATION CRITERIA FOR RA AS GUIDANCE FOR TREATMENT SELECTION IN AN EARLY ARTHRITIS COHORT: 2010 CRITERIA LEAD TO HIGHER RATES OF CLINICAL REMISSION

S. Balduzzi - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

Filters

1151 Abstracts